Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Astrazeneca Plc ADR
(NQ:
AZN
)
78.56
+0.14 (+0.18%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Astrazeneca Plc ADR
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
54
55
Next >
2 Top Biotech Stocks to Buy Right Now
April 07, 2023
These two companies pay market-beating dividends to shareholders.
Via
The Motley Fool
7 Very Undervalued Penny Stocks to Buy in April 2023
April 06, 2023
Undervalued penny stocks present investors who are very bullish on the near-term future with a high-risk, high-reward option.
Via
InvestorPlace
AstraZeneca PLC (NASDAQ: AZN) Climbs to New 52-Week High
April 06, 2023
Via
Investor Brand Network
Check Out What Whales Are Doing With AZN
April 05, 2023
Via
Benzinga
Astrazeneca Plc (NASDAQ: AZN) Highlighted for Surprising Price Action
April 05, 2023
Via
Investor Brand Network
Medical Behemoth AstraZeneca Flirts With Breakout On Fresh Hope In Ovarian Cancer
April 05, 2023
A combination of four drugs improved outcomes in ovarian cancer treatment.
Via
Investor's Business Daily
A Look Into AstraZeneca Inc's Price Over Earnings
March 31, 2023
Via
Benzinga
A Look Into AstraZeneca's Debt
March 31, 2023
Via
Benzinga
AstraZeneca Unusual Options Activity
March 27, 2023
Via
Benzinga
2 Steady Stocks to Buy and Hold Forever
March 17, 2023
Investing in these companies can help you sleep easy at night.
Via
The Motley Fool
P/E Ratio Insights for AstraZeneca
March 16, 2023
Via
Benzinga
AstraZeneca' Cancer Drug Combo Meets Goal In Late-Stage Ovarian Cancer Study
April 05, 2023
Via
Benzinga
COVID Remains A Global Threat – NanoViricides Set To Begin Clinical Trials For Pan-Coronavirus Drug To Help Defeat COVID Once And For All
March 31, 2023
Effective treatments for COVID-19 remain very few and very limited in their capabilities, even after three years. As a result, there are still high rates of hospitalizations and COVID remains many...
Via
Benzinga
7 Growth Stocks That Pay Generous Dividends
March 30, 2023
With these seven dividend-paying growth stocks, steady payouts plus underlying growth could produce strong long-term total returns.
Via
InvestorPlace
Pieris Pharma Pushes Elarekibep Data Readout, Investors React Negatively
March 29, 2023
Via
Benzinga
AstraZeneca Axes Pneumonia Drug Pact With Aridis
March 29, 2023
AstraZeneca plc (NASDAQ: AZN) scrapped its license agreement with Aridis Pharmaceuticals Inc (NASDAQ: ARDS).
Via
Benzinga
A Look Into AstraZeneca's Debt
March 15, 2023
Via
Benzinga
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
March 27, 2023
Sanofi and Regeneron bolted higher on news about their jointly developed COPD medication Dupixent. Analysts say sales may hit $20 billion within a decade.
Via
MarketBeat
AstraZeneca-Ionis Partnered Rare Disease Drug Data Shows Sustained Benefit; Drug Under FDA Review
March 27, 2023
Via
Benzinga
Eplontersen demonstrated sustained benefit in Phase III trial for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) through 66 weeks
March 27, 2023
From
AstraZeneca
Via
Business Wire
7 Blue-Chip Stocks to Buy for Capital Preservation
March 23, 2023
These are the low-beta blue-chip stocks to buy as they represent companies with a strong balance sheet and healthy cash flow potential.
Via
InvestorPlace
3 Exceptionally Safe Dividend Stocks That Can Turn $400,000 Into $1 Million by 2030
March 23, 2023
These historically profitable dividend-paying stocks are ideal for risk-averse investors wanting to take advantage of a bear market discount.
Via
The Motley Fool
Nvidia Ramps Up Artificial Intelligence Offerings Amid AI's 'iPhone Moment'
March 21, 2023
Nvidia on Tuesday demonstrated how its technology is advancing artificial intelligence in myriad industries. Nvidia stock has soared in 2023.
Via
Investor's Business Daily
Where Did COVID-19 Really Originate? Biden Signs Bill To Declassify Origins Information
March 21, 2023
Via
Benzinga
GSK's Chief Scientist Says R&D Focus More On Infectious Disease, HIV Amid Patent Expiration, Dwindling Sales
March 15, 2023
GSK Plc's (NYSE: GSK) top scientist, Tony Wood, who took the helm of R&D last August, says the R&D department is now delivering results. Wood said he is de-emphasizing R&D in oncology and that the R&D...
Via
Benzinga
Rise in Biotech Innovations Generating Hope as Pancreatic Cancer Survival Rates Climb
March 14, 2023
FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 14, 2023 – USA News Group – Optimism is on the rise as the American Cancer Society is reporting that the five-year survival...
Via
FinancialNewsMedia
Exposures
Product Safety
AstraZenceca's Tagrisso Shows Survival Benefit In Early-Stage Lung Cancer Settings
March 09, 2023
Via
Benzinga
AstraZeneca's Immunotherapy Imfinzi Shows Improvement In Survival Chances In Lung Cancer Patients
March 09, 2023
Via
Benzinga
TAGRISSO® (osimertinib) demonstrated strong overall survival benefit in the ADAURA Phase III trial for adjuvant treatment of patients with early-stage EGFR-mutated lung cancer
March 09, 2023
From
AstraZeneca
Via
Business Wire
IMFINZI significantly improved event-free survival in AEGEAN Phase III trial for patients with resectable non-small cell lung cancer
March 09, 2023
From
AstraZeneca
Via
Business Wire
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
54
55
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.